Stryker price target lowered to $422 from $427 at Goldman Sachs

Goldman Sachs lowered the firm’s price target on Stryker (SYK) to $422 from $427 and keeps a Neutral rating on the shares. The firm is updating its model to reflect the company’s Inari acquisition and the $3B of debt taken on to fund the acquisition, the analyst tells investors in a research note. Goldman adds however that following the deal, it sees 2025-2028 revenue growth of 8.2% vs. 7.9% previously.